Europe • Euronext Paris • EPA:ALTRI • FR0010397901
We assign a fundamental rating of 5 out of 10 to ALTRI. ALTRI was compared to 112 industry peers in the Machinery industry. While ALTRI has a great health rating, its profitability is only average at the moment. ALTRI has a valuation in line with the averages, but on the other hand it scores bad on growth.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.53% | ||
| ROE | 2.8% | ||
| ROIC | 0.57% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.16% | ||
| PM (TTM) | 4.57% | ||
| GM | 63.63% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Altman-Z | 5.48 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.71 | ||
| Quick Ratio | 8.58 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.76 | ||
| Fwd PE | 14.29 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.74 | ||
| EV/EBITDA | -23.84 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 4 / 10 to ALTRI.PA.
ChartMill assigns a valuation rating of 3 / 10 to TRILOGIQ (ALTRI.PA). This can be considered as Overvalued.
TRILOGIQ (ALTRI.PA) has a profitability rating of 4 / 10.
The financial health rating of TRILOGIQ (ALTRI.PA) is 9 / 10.
The Earnings per Share (EPS) of TRILOGIQ (ALTRI.PA) is expected to decline by -2.78% in the next year.